Galectin Therapeutics (GALT) Dividends Paid - Common (2019)

Galectin Therapeutics (GALT) recorded quarterly Dividends Paid - Common of $1000.0 in Q2 2019, down 99.75% quarter-over-quarter from $395000.0 in Q1 2019.

Galectin Therapeutics (GALT) Dividends Paid - Common (2019) Analysis & Trends

Galectin Therapeutics' Dividends Paid - Common history runs 1 years deep, the most recent figure standing at $1000.0 for Q2 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends Paid - Common (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Galectin Therapeutics 185.83 Mn 171.73 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2019 1,000.00
Jun 30, 2019 1,000.00
Mar 31, 2019 395,000.00
Mar 31, 2019 395,000.00